Cargando…
Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19
The disease course of COVID-19 in patients with immunodeficiencies is unclear, as well as the optimal therapeutic strategy. We report a case of a 37-year old male with common variable immunodeficiency disorder and a severe SARS-CoV-2 infection. After administration of convalescent plasma, the patien...
Autores principales: | Van Damme, Karel F. A., Tavernier, Simon, Van Roy, Nele, De Leeuw, Elisabeth, Declercq, Jozefien, Bosteels, Cédric, Maes, Bastiaan, De Bruyne, Marieke, Bogaert, Delfien, Bosteels, Victor, Hoste, Levi, Naesens, Leslie, Maes, Piet, Grifoni, Alba, Weiskopf, Daniela, Sette, Alessandro, Depuydt, Pieter, Van Braeckel, Eva, Haerynck, Filomeen, Lambrecht, Bart N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714937/ https://www.ncbi.nlm.nih.gov/pubmed/33329586 http://dx.doi.org/10.3389/fimmu.2020.596761 |
Ejemplares similares
-
A Computational Pipeline for the Diagnosis of CVID Patients
por: Emmaneel, Annelies, et al.
Publicado: (2019) -
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022) -
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial
por: De Leeuw, Elisabeth, et al.
Publicado: (2022) -
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
por: Declercq, Jozefien, et al.
Publicado: (2021) -
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial
por: Declercq, Jozefien, et al.
Publicado: (2020)